Determination of Serum Triacylglyceride Reduction Using Patented Microbial Lipase

Abstract

Conclusions:The majority of patients with VSHTG are underdiagnosed and undertreated. There is significant unmet need in this area. It is essential to increase physician/ patient disease education and to institute more appropriate pharmacologic intervention that effectively reduces TG levels.